milrinone has been researched along with thromboplastin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beppu, S; Kageyama, K; Matsuda, N; Mizobe, T; Nakajima, Y; Shibasaki, M; Shime, N | 1 |
1 trial(s) available for milrinone and thromboplastin
Article | Year |
---|---|
Phosphodiesterase 3 inhibition reduces platelet activation and monocyte tissue factor expression in knee arthroplasty patients.
Topics: Aged; Anesthesia, General; Arthroplasty, Replacement, Knee; Blood Coagulation; Blood Platelets; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Flow Cytometry; Humans; Male; Middle Aged; Milrinone; Mitogen-Activated Protein Kinases; Monocytes; Oncogene Protein v-akt; P-Selectin; Phosphatidylinositol 3-Kinases; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Platelet Activation; Prospective Studies; Thromboplastin | 2009 |